AvacopanMeSH Supplementary Concept

https://www.has-sante.fr/jcms/p_3421374/fr/tavneos-avacopan
2023
false
false
false
France
insurance, health, reimbursement
adult
avacopan
drug therapy, combination
Granulomatosis with Polyangiitis
microscopic polyangiitis
Rituximab
cyclophosphamide
treatment outcome
evaluation of the transparency committee
avacopan

---
https://ansm.sante.fr/tableau-acces-derogatoire/vynpenta-10-mg-comprime
2023
false
false
false
France
French
drug information
insurance, health, reimbursement
avacopan
avacopan
administration, oral
tablets
drug therapy, combination
Granulomatosis with Polyangiitis
microscopic polyangiitis

---
https://www.has-sante.fr/jcms/p_3375770/fr/tavneos-avacopan
2022
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
receptor, anaphylatoxin c5a
adult
Granulomatosis with Polyangiitis
microscopic polyangiitis
drug therapy, combination
cyclophosphamide
Rituximab
avacopan
evaluation of the transparency committee
avacopan

---
https://www.cadth.ca/fr/avacopan
2022
false
false
false
false
Canada
French
English
drug information
avacopan

---
https://www.has-sante.fr/jcms/p_3318727/fr/tavneos-avacopan
https://www.has-sante.fr/jcms/p_3318745/fr/decision-n-2022-0067/dc/sem-du-17-fevrier-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-tavneos
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
Rituximab
cyclophosphamide
adult
Granulomatosis with Polyangiitis
microscopic polyangiitis
package leaflet
summary of product characteristics
guidelines for drug use
administration, oral
continuity of patient care
data collection
avacopan
C5a Anaphylatoxin Chemotactic Receptor 1
C5AR1 protein, human
forms
avacopan
evaluation of the transparency committee
avacopan

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tavneos
2022
false
false
false
Netherlands
French
English
avacopan
avacopan
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
drug approval
europe
adult
aged
Granulomatosis with Polyangiitis
microscopic polyangiitis
drug therapy, combination
administration, oral
receptor, anaphylatoxin c5a
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
avacopan

---